Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

TRANSPLANTATION IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA FROM A MATCHED DONOR VERSUS AN HLA-IDENTICAL SIBLING: IS THE OUTCOME COMPARABLE? RESULTS FROM THE INTERNATIONAL BFM ALL SCT 2007 STUDY.

Balduzzi A, Dalle JH, Wachowiak J, Yaniv I, Yesilipek A, Sedlacek P, Bierings M, Ifversen M, Sufliarska S, Kalwak K, Lankester A, Toporski J, Maio LD, Glogova E, Poetschger U, Peters C.

Biol Blood Marrow Transplant. 2019 Jul 15. pii: S1083-8791(19)30443-4. doi: 10.1016/j.bbmt.2019.07.011. [Epub ahead of print]

PMID:
31319153
2.

Leukocyte Counts and Other Hematological Values in Twin-Twin Transfusion Syndrome and Twin Anemia-Polycythemia Sequence.

Visser GL, Tollenaar LSA, Bekker V, Te Pas AB, Lankester AC, Oepkes D, Lopriore E, Verbeek L.

Fetal Diagn Ther. 2019 Jul 1:1-6. doi: 10.1159/000500859. [Epub ahead of print]

3.

Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation.

van der Stoep MYEC, Zwaveling J, Bertaina A, Locatelli F, Guchelaar HJ, Lankester AC, Moes DJAR.

Br J Clin Pharmacol. 2019 May 29. doi: 10.1111/bcp.13995. [Epub ahead of print]

PMID:
31144349
4.

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome.

Admiraal R, Jol-van der Zijde CM, Furtado Silva JM, Knibbe CAJ, Lankester AC, Boelens JJ, Hale G, Etuk A, Wilson M, Adams S, Veys P, van Kesteren C, Bredius RGM.

Clin Pharmacokinet. 2019 May 27. doi: 10.1007/s40262-019-00782-0. [Epub ahead of print]

PMID:
31131436
5.

Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant.

Faraci M, Diesch T, Labopin M, Dalissier A, Lankester A, Gennery A, Sundin M, Uckan-Cetinkaya D, Bierings M, Peters AMJ, Garwer M, Schulz A, Michel G, Giorgiani G, Gruhn B, Locatelli F, Giardino S, Uyttebroeck A, Rialland F, Itäla-Remes M, Dreger P, Shaw PJ, Bordon V, Schlegel PG, Mellgren K, Moraleda JM, Patrick K, Schneider P, Jubert C, Lawitschka A, Salooja N, Basak GW, Corbacioglu S, Duarte R, Bader P; Pediatric and Transplant Complications Working Parties of the European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2019 May 11. pii: S1083-8791(19)30289-7. doi: 10.1016/j.bbmt.2019.05.005. [Epub ahead of print]

PMID:
31082473
6.

B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children.

van der Maas NG, Berghuis D, van der Burg M, Lankester AC.

Front Immunol. 2019 Apr 12;10:782. doi: 10.3389/fimmu.2019.00782. eCollection 2019. Review.

7.

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.

Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, Corbacioglu S, Dreger P, Dufour C, Gennery AR, Kuball J, Lankester AC, Lanza F, Montoto S, Nagler A, Peffault de Latour R, Snowden JA, Styczynski J, Yakoub-Agha I, Kröger N, Mohty M; European Society for Blood and Marrow Transplantation (EBMT).

Bone Marrow Transplant. 2019 Apr 5. doi: 10.1038/s41409-019-0516-2. [Epub ahead of print]

PMID:
30953028
8.

Determining the extent of maternal-foetal chimerism in cord blood.

Opstelten R, Slot MC, Lardy NM, Lankester AC, Mulder A, Claas FHJ, van Rood JJ, Amsen D.

Sci Rep. 2019 Mar 27;9(1):5247. doi: 10.1038/s41598-019-41733-w.

9.

Effects of immunomodulation in classic infantile Pompe patients with high antibody titers.

Poelman E, Hoogeveen-Westerveld M, van den Hout JMP, Bredius RGM, Lankester AC, Driessen GJA, Kamphuis SSM, Pijnappel WWM, van der Ploeg AT.

Orphanet J Rare Dis. 2019 Mar 22;14(1):71. doi: 10.1186/s13023-019-1039-z.

10.

Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation.

Oostenbrink LVE, Jol-van der Zijde CM, Kielsen K, Jansen-Hoogendijk AM, Ifversen M, Müller KG, Lankester AC, van Halteren AGS, Bredius RGM, Schilham MW, van Tol MJD.

Front Immunol. 2019 Mar 6;10:315. doi: 10.3389/fimmu.2019.00315. eCollection 2019.

11.

The Escherichia coli multiple antibiotic resistance activator protein represses transcription of the lac operon.

Lankester A, Ahmed S, Lamberte LE, Kettles RA, Grainger DC.

Biochem Soc Trans. 2019 Apr 30;47(2):671-677. doi: 10.1042/BST20180498. Epub 2019 Mar 8. Review.

PMID:
30850424
12.

Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation.

Bekker V, Zwittink RD, Knetsch CW, Sanders IMJG, Berghuis D, Heidt PJ, Vossen JMJJ, de Vos WM, Belzer C, Bredius RGM, Van't Hof PJ, Lankester AC, Kuijper EJ.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1164-1171. doi: 10.1016/j.bbmt.2019.01.037. Epub 2019 Feb 5.

PMID:
30731251
13.

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.

Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A, Montoto S, de Latour RP, Snowden JA, Styczynski J, Yakoub-Agha I, Arat M, Mohty M, Kröger N; European Society for Blood and Marrow Transplantation (EBMT).

Bone Marrow Transplant. 2019 Feb 6. doi: 10.1038/s41409-019-0465-9. [Epub ahead of print]

14.

Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.

Ferrua F, Galimberti S, Courteille V, Slatter MA, Booth C, Moshous D, Neven B, Blanche S, Cavazzana M, Laberko A, Shcherbina A, Balashov D, Soncini E, Porta F, Al-Mousa H, Al-Saud B, Al-Dhekri H, Arnaout R, Formankova R, Bertrand Y, Lange A, Smart J, Wolska-Kusnierz B, Aquino VM, Dvorak CC, Fasth A, Fouyssac F, Heilmann C, Hoenig M, Schuetz C, Kelečić J, Bredius RGM, Lankester AC, Lindemans CA, Suarez F, Sullivan KE, Albert MH, Kałwak K, Barlogis V, Bhatia M, Bordon V, Czogala W, Alonso L, Dogu F, Gozdzik J, Ikinciogullari A, Kriván G, Ljungman P, Meyts I, Mustillo P, Smith AR, Speckmann C, Sundin M, Keogh SJ, Shaw PJ, Boelens JJ, Schulz AS, Sedlacek P, Veys P, Mahlaoui N, Janda A, Davies EG, Fischer A, Cowan MJ, Gennery AR; SCETIDE, PIDTC, EBMT & ESID IEWP.

J Allergy Clin Immunol. 2019 Jun;143(6):2238-2253. doi: 10.1016/j.jaci.2018.12.1010. Epub 2019 Jan 17.

15.

Late effects of pediatric hematopoietic stem cell transplantation on left ventricular function, aortic stiffness and myocardial tissue characteristics.

Paiman EHM, Louwerens M, Bresters D, Westenberg JJM, Tao Q, van der Geest RJ, Lankester AC, Roest AAW, Lamb HJ.

J Cardiovasc Magn Reson. 2019 Jan 17;21(1):6. doi: 10.1186/s12968-018-0513-4.

16.

Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group.

Bomken S, van der Werff Ten Bosch J, Attarbaschi A, Bacon CM, Borkhardt A, Boztug K, Fischer U, Hauck F, Kuiper RP, Lammens T, Loeffen J, Neven B, Pan-Hammarström Q, Quinti I, Seidel MG, Warnatz K, Wehr C, Lankester AC, Gennery AR.

Front Immunol. 2018 Dec 12;9:2912. doi: 10.3389/fimmu.2018.02912. eCollection 2018. Review.

17.

Solid organ transplantation after hematopoietic stem cell transplantation in childhood: A multicentric retrospective survey.

Faraci M, Bertaina A, Dalissier A, Ifversen M, Schulz A, Gennery A, Burkhardt B, Badell Serra I, Diaz-de-Heredia C, Lanino E, Lankester AC, Gruhn B, Matthes-Martin S, Kühl JS, Varotto S, Paillard C, Guilmatre A, Sastre A, Abecasis M, Garwer B, Sedlacek P, Boelens JJ, Beohou E, Bader P; EBMT Pediatric Disease Working Party.

Am J Transplant. 2019 Jun;19(6):1798-1805. doi: 10.1111/ajt.15240. Epub 2019 Jan 25.

PMID:
30586230
18.

Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis.

Furtado-Silva JM, Paviglianiti A, Ruggeri A, Boelens JJ, Veys P, Ahmari AA, Zecca M, Locatelli F, Michel G, Volt F, Kenzey C, Sedlacek P, Rao K, Lankester A, Gluckman E, Rocha V; Eurocord/ Monacord, Cord Blood Committee of Cellular Therapy, Immunobiology and Inborn Errors Working Parties of the European Blood and Marrow Transplant Group.

Br J Haematol. 2019 Feb;184(3):397-404. doi: 10.1111/bjh.15642. Epub 2018 Nov 21.

PMID:
30460979
19.

Human Bone Marrow-Resident Natural Killer Cells Have a Unique Transcriptional Profile and Resemble Resident Memory CD8+ T Cells.

Melsen JE, Lugthart G, Vervat C, Kielbasa SM, van der Zeeuw SAJ, Buermans HPJ, van Ostaijen-Ten Dam MM, Lankester AC, Schilham MW.

Front Immunol. 2018 Aug 22;9:1829. doi: 10.3389/fimmu.2018.01829. eCollection 2018.

20.

Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model.

Thielen FW, Blommestein HM, Oosten LEM, Calkoen FG, Lankester AC, Zwaginga JJ, Le Blanc K, Redondo A, Sánchez-Guijo F, Algeri M, Locatelli F, Fibbe WE, Uyl-de Groot CA.

Eur J Haematol. 2018 Aug 6. doi: 10.1111/ejh.13158. [Epub ahead of print]

PMID:
30084111
21.

Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor Profiles.

de Haan N, van Tol MJD, Driessen GJ, Wuhrer M, Lankester AC.

Front Immunol. 2018 Jun 4;9:1238. doi: 10.3389/fimmu.2018.01238. eCollection 2018.

22.

Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes.

Dalle JH, Balduzzi A, Bader P, Lankester A, Yaniv I, Wachowiak J, Pieczonka A, Bierings M, Yesilipek A, Sedlaçek P, Ifversen M, Sufliarska S, Toporski J, Glogova E, Poetschger U, Peters C.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1848-1855. doi: 10.1016/j.bbmt.2018.05.009. Epub 2018 May 14.

PMID:
29772352
23.

Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation.

Mohty M, Duarte RF, Kuball J, Bader P, Basak GW, Bonini C, Carreras E, Chabannon C, Dufour C, Gennery A, Lankester A, Lanza F, Ljungman P, Montoto S, Nagler A, Snowden JA, Styczynski J, Sureda A, Kröger N.

Bone Marrow Transplant. 2018 Dec;53(12):1548-1552. doi: 10.1038/s41409-018-0190-9. Epub 2018 May 2.

PMID:
29720705
24.

Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report.

Passweg JR, Baldomero H, Bader P, Basak GW, Bonini C, Duarte R, Dufour C, Kröger N, Kuball J, Lankester A, Montoto S, Nagler A, Snowden JA, Styczynski J, Mohty M; European Society for Blood and Marrow Transplantation (EBMT).

Bone Marrow Transplant. 2018 Sep;53(9):1139-1148. doi: 10.1038/s41409-018-0153-1. Epub 2018 Mar 14.

25.

Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients.

Kruizinga MD, van Tol MJD, Bekker V, Netelenbos T, Smiers FJ, Bresters D, Jansen-Hoogendijk AM, van Ostaijen-Ten Dam MM, Kollen WJW, Zwaginga JJ, Lankester AC, Bredius RGM.

Biol Blood Marrow Transplant. 2018 Apr;24(4):772-778. doi: 10.1016/j.bbmt.2017.12.782. Epub 2017 Dec 19.

26.

CAR-T cells: the narrow path between hope and bankruptcy?

Chabannon C, Kuball J, Mcgrath E, Bader P, Dufour C, Lankester A, Basak GW, Montoto S, Nagler A, Snowden JA, Styczynski J, Duarte RF, Kröger N, Mohty M.

Bone Marrow Transplant. 2017 Dec;52(12):1588-1589. doi: 10.1038/bmt.2017.241. No abstract available.

PMID:
29209061
27.

High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study.

van der Stoep MYEC, Bertaina A, Ten Brink MH, Bredius RG, Smiers FJ, Wanders DCM, Moes DJAR, Locatelli F, Guchelaar HJ, Zwaveling J, Lankester AC.

Br J Haematol. 2017 Dec;179(5):772-780. doi: 10.1111/bjh.14960. Epub 2017 Oct 19.

PMID:
29048102
28.

In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir.

Bastiaans DET, Immohr LI, Zeinstra GG, Strik-Albers R, Pein-Hackelbusch M, van der Flier M, de Haan AFJ, Boelens JJ, Lankester AC, Burger DM, Warris A.

Br J Clin Pharmacol. 2017 Dec;83(12):2789-2797. doi: 10.1111/bcp.13396. Epub 2017 Sep 20.

29.

Expansion of cytotoxic CD56bright natural killer cells during T-cell deficiency after allogeneic hematopoietic stem cell transplantation.

Lugthart G, Goedhart M, van Leeuwen MM, Melsen JE, Jol-van der Zijde CM, Vervat C, van Ostaijen-Ten Dam MM, Jansen-Hoogendijk AM, van Tol MJD, Lankester AC, Schilham MW.

J Allergy Clin Immunol. 2017 Nov;140(5):1466-1469. doi: 10.1016/j.jaci.2017.06.039. Epub 2017 Aug 1. No abstract available.

PMID:
28778795
30.

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.

Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, Dignan F, Gibson B, Guengoer T, Gruhn B, Lankester A, Locatelli F, Pagliuca A, Peters C, Richardson PG, Schulz AS, Sedlacek P, Stein J, Sykora KW, Toporski J, Trigoso E, Vetteranta K, Wachowiak J, Wallhult E, Wynn R, Yaniv I, Yesilipek A, Mohty M, Bader P.

Bone Marrow Transplant. 2018 Feb;53(2):138-145. doi: 10.1038/bmt.2017.161. Epub 2017 Jul 31.

31.

Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group.

Balduzzi A, Dalle JH, Jahnukainen K, von Wolff M, Lucchini G, Ifversen M, Macklon KT, Poirot C, Diesch T, Jarisch A, Bresters D, Yaniv I, Gibson B, Willasch AM, Fadini R, Ferrari L, Lawitschka A, Ahler A, Sänger N, Corbacioglu S, Ansari M, Moffat R, Dalissier A, Beohou E, Sedlacek P, Lankester A, De Heredia Rubio CD, Vettenranta K, Wachowiak J, Yesilipek A, Trigoso E, Klingebiel T, Peters C, Bader P.

Bone Marrow Transplant. 2017 Oct;52(10):1406-1415. doi: 10.1038/bmt.2017.147. Epub 2017 Jul 24.

PMID:
28737775
32.

Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency.

Petersheim D, Massaad MJ, Lee S, Scarselli A, Cancrini C, Moriya K, Sasahara Y, Lankester AC, Dorsey M, Di Giovanni D, Bezrodnik L, Ohnishi H, Nishikomori R, Tanita K, Kanegane H, Morio T, Gelfand EW, Jain A, Secord E, Picard C, Casanova JL, Albert MH, Torgerson TR, Geha RS.

J Allergy Clin Immunol. 2018 Mar;141(3):1060-1073.e3. doi: 10.1016/j.jaci.2017.05.030. Epub 2017 Jun 17.

33.

Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection.

Theunissen PMJ, Sedek L, De Haas V, Szczepanski T, Van Der Sluijs A, Mejstrikova E, Nováková M, Kalina T, Lecrevisse Q, Orfao A, Lankester AC, van Dongen JJM, Van Der Velden VHJ; EuroFlow Consortium.

Br J Haematol. 2017 Jul;178(2):257-266. doi: 10.1111/bjh.14682. Epub 2017 Apr 17.

PMID:
28419441
34.

State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015.

Dalle JH, Lucchini G, Balduzzi A, Ifversen M, Jahnukainen K, Macklon KT, Ahler A, Jarisch A, Ansari M, Beohou E, Bresters D, Corbacioglu S, Dalissier A, Diaz de Heredia Rubio C, Diesch T, Gibson B, Klingebiel T, Lankester A, Lawitschka A, Moffat R, Peters C, Poirot C, Saenger N, Sedlacek P, Trigoso E, Vettenranta K, Wachowiak J, Willasch A, von Wolff M, Yaniv I, Yesilipek A, Bader P.

Bone Marrow Transplant. 2017 Jul;52(7):1029-1035. doi: 10.1038/bmt.2017.21. Epub 2017 Mar 13.

PMID:
28287638
35.

Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections.

Wentink M, Dalm V, Lankester AC, van Schouwenburg PA, Schölvinck L, Kalina T, Zachova R, Sediva A, Lambeck A, Pico-Knijnenburg I, van Dongen JJ, Pac M, Bernatowska E, van Hagen M, Driessen G, van der Burg M.

Clin Immunol. 2017 Mar;176:77-86. doi: 10.1016/j.clim.2017.01.004. Epub 2017 Jan 17.

PMID:
28104464
36.

The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients.

Kruizinga MD, Bresters D, Smiers FJ, Lankester AC, Bredius RGM.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26453. Epub 2017 Jan 11.

PMID:
28074607
37.

Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.

Lucchini G, Labopin M, Beohou E, Dalissier A, Dalle JH, Cornish J, Zecca M, Samarasinghe S, Gibson B, Locatelli F, Bertrand Y, Abdel-Rahman F, Socie G, Sundin M, Lankester A, Sedlacek P, Hamladji RM, Heilmann C, Afanasyev B, Hough R, Peters C, Bader P, Veys P.

Biol Blood Marrow Transplant. 2017 Mar;23(3):467-474. doi: 10.1016/j.bbmt.2016.11.022. Epub 2016 Dec 1.

38.

The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

van Walraven SM, Brand A, Bakker JN, Heemskerk MB, Nillesen S, Bierings MB, Bungener LB, Hepkema BG, Lankester A, van der Meer A, Sintnicolaas K, Somers JA, Spierings E, Tilanus MG, Voorter CE, Cornelissen JJ, Oudshoorn M.

Haematologica. 2017 Jan;102(1):176-183. doi: 10.3324/haematol.2016.145730. Epub 2016 Aug 25.

39.

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations.

Melsen JE, Lugthart G, Lankester AC, Schilham MW.

Front Immunol. 2016 Jun 30;7:262. doi: 10.3389/fimmu.2016.00262. eCollection 2016. Review.

40.

Hematopoietic Stem Cell Transplantation in a Patient With ICF2 Syndrome Presenting With EBV-Induced Hemophagocytic Lymphohystiocytosis.

Harnisch E, Buddingh EP, Thijssen PE, Brooks AS, Driessen GJ, Kersseboom R, Lankester AC.

Transplantation. 2016 Jul;100(7):e35-6. doi: 10.1097/TP.0000000000001210. No abstract available.

PMID:
27326813
41.

Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.

Lugthart G, Melsen JE, Vervat C, van Ostaijen-Ten Dam MM, Corver WE, Roelen DL, van Bergen J, van Tol MJ, Lankester AC, Schilham MW.

J Immunol. 2016 Jul 1;197(1):78-84. doi: 10.4049/jimmunol.1502603. Epub 2016 May 25.

42.

Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients: Protocol Optimization and Therapeutic Potential.

van Ostaijen-ten Dam MM, Prins HJ, Boerman GH, Vervat C, Pende D, Putter H, Lankester A, van Tol MJ, Zwaginga JJ, Schilham MW.

J Immunother. 2016 Feb-Mar;39(2):90-100. doi: 10.1097/CJI.0000000000000110.

PMID:
26849078
43.

Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.

Wlodarski MW, Hirabayashi S, Pastor V, Starý J, Hasle H, Masetti R, Dworzak M, Schmugge M, van den Heuvel-Eibrink M, Ussowicz M, De Moerloose B, Catala A, Smith OP, Sedlacek P, Lankester AC, Zecca M, Bordon V, Matthes-Martin S, Abrahamsson J, Kühl JS, Sykora KW, Albert MH, Przychodzien B, Maciejewski JP, Schwarz S, Göhring G, Schlegelberger B, Cseh A, Noellke P, Yoshimi A, Locatelli F, Baumann I, Strahm B, Niemeyer CM; EWOG-MDS.

Blood. 2016 Mar 17;127(11):1387-97; quiz 1518. doi: 10.1182/blood-2015-09-669937. Epub 2015 Dec 23.

44.

Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.

Admiraal R, van Kesteren C, Jol-van der Zijde CM, Lankester AC, Bierings MB, Egberts TC, van Tol MJ, Knibbe CA, Bredius RG, Boelens JJ.

Lancet Haematol. 2015 May;2(5):e194-203. doi: 10.1016/S2352-3026(15)00045-9. Epub 2015 Apr 21.

PMID:
26688094
45.

Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patients.

Nierkens S, Lankester AC, Egeler RM, Bader P, Locatelli F, Pulsipher MA, Bollard CM, Boelens JJ; Westhafen Intercontinental Group.

Cytotherapy. 2015 Dec;17(12):1667-74. doi: 10.1016/j.jcyt.2015.09.008. Review.

PMID:
26589751
46.

Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells.

Wiekmeijer AS, Pike-Overzet K, IJspeert H, Brugman MH, Wolvers-Tettero IL, Lankester AC, Bredius RG, van Dongen JJ, Fibbe WE, Langerak AW, van der Burg M, Staal FJ.

J Allergy Clin Immunol. 2016 Feb;137(2):517-526.e3. doi: 10.1016/j.jaci.2015.08.022. Epub 2015 Oct 4.

PMID:
26441229
47.

European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies.

Boztug H, Sykora KW, Slatter M, Zecca M, Veys P, Lankester A, Cant A, Skinner R, Wachowiak J, Glogova E, Pötschger U, Peters C.

Pediatr Blood Cancer. 2016 Jan;63(1):139-48. doi: 10.1002/pbc.25764. Epub 2015 Sep 23.

PMID:
26398915
48.

Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases.

Slatter MA, Boztug H, Pötschger U, Sykora KW, Lankester A, Yaniv I, Sedlacek P, Glogova E, Veys P, Gennery AR, Peters C; EBMT Inborn Errors and Paediatric Diseases Working Parties.

Bone Marrow Transplant. 2015 Dec;50(12):1536-41. doi: 10.1038/bmt.2015.171. Epub 2015 Aug 10.

PMID:
26259076
49.

Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.

Verhoeven DH, Claas EC, Jol-van der Zijde CM, Thijssen JC, Lankester AC, Bredius RG, Putter H, Kroes AC, Egeler RM, Schilham MW, van Tol MJ.

Pediatr Infect Dis J. 2015 Oct;34(10):1118-27. doi: 10.1097/INF.0000000000000824.

PMID:
26132825
50.

Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency.

van Schaarenburg RA, Schejbel L, Truedsson L, Topaloglu R, Al-Mayouf SM, Riordan A, Simon A, Kallel-Sellami M, Arkwright PD, Åhlin A, Hagelberg S, Nielsen S, Shayesteh A, Morales A, Tam S, Genel F, Berg S, Ketel AG, Merlijn van den Berg J, Kuijpers TW, Olsson RF, Huizinga TW, Lankester AC, Trouw LA.

J Autoimmun. 2015 Aug;62:39-44. doi: 10.1016/j.jaut.2015.06.002. Epub 2015 Jun 26.

PMID:
26119135

Supplemental Content

Loading ...
Support Center